Gefen’s investment strategy is focused on Healthcare, Energy and Clean Technologies in diversified fields. Investment decisions and evaluation is performed according to the analysis of 3 main elements: People, Product & Market. Gefen is looking for experienced entrepreneurs who lead extra-ordinary management teams to build a great product based a remarkable technology the overlooks a vast potential market.
Gefen evaluates 6 areas of risk: Market and competition, Technology, Legal (including IP and reimbursement), Management, Deal structure and valuation and potential Exit.
Proactive search in specific sector is done per opportunity and can be further implemented per specific collaboration.
Investment criteria includes significant risk reduction within 18 – 24 months in the development and clinical program.
Focus on completion of pre-clinical stage during the investment round, reaching clinical trials and first in man.
A typical deal usually includes a seed investment of 500,000 – 1,000,000 USD per company including OCS funds, where 50%- 85% of the investment is funded by the OCS as a non-recourse, for 30-50% of issued shares and monitoring the companies by active board position and financial management.